GPCR Therapeutics (GPC-100 (Rights) in Taiwan) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

GPCR Therapeutics (GPC-100 (Rights) in Taiwan) General Information

Description

Portfolio of exclusive rights to GPC-100 located in Taiwan.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Taiwan
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Apt Neuroscience
Corporate Office
  • Taiwan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GPCR Therapeutics (GPC-100 (Rights) in Taiwan) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GPCR Therapeutics (GPC-100 (Rights) in Taiwan)‘s full profile, request access.

Request a free trial

GPCR Therapeutics (GPC-100 (Rights) in Taiwan) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GPCR Therapeutics (GPC-100 (Rights) in Taiwan)‘s full profile, request access.

Request a free trial

GPCR Therapeutics (GPC-100 (Rights) in Taiwan) FAQs

  • Where is GPCR Therapeutics (GPC-100 (Rights) in Taiwan) headquartered?

    GPCR Therapeutics (GPC-100 (Rights) in Taiwan) is headquartered in Taiwan.

  • What industry is GPCR Therapeutics (GPC-100 (Rights) in Taiwan) in?

    GPCR Therapeutics (GPC-100 (Rights) in Taiwan)’s primary industry is Buildings and Property.

  • Is GPCR Therapeutics (GPC-100 (Rights) in Taiwan) a private or public company?

    GPCR Therapeutics (GPC-100 (Rights) in Taiwan) is a Private company.

  • What is the current valuation of GPCR Therapeutics (GPC-100 (Rights) in Taiwan)?

    The current valuation of GPCR Therapeutics (GPC-100 (Rights) in Taiwan) is .

  • What is GPCR Therapeutics (GPC-100 (Rights) in Taiwan)’s current revenue?

    The current revenue for GPCR Therapeutics (GPC-100 (Rights) in Taiwan) is .

  • Who are GPCR Therapeutics (GPC-100 (Rights) in Taiwan)’s investors?

    GPCR Therapeutics and TaiGen Biotechnology have invested in GPCR Therapeutics (GPC-100 (Rights) in Taiwan).

  • When was GPCR Therapeutics (GPC-100 (Rights) in Taiwan) acquired?

    GPCR Therapeutics (GPC-100 (Rights) in Taiwan) was acquired on 26-Aug-2026.

  • Who acquired GPCR Therapeutics (GPC-100 (Rights) in Taiwan)?

    GPCR Therapeutics (GPC-100 (Rights) in Taiwan) was acquired by Apt Neuroscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process